![Changgeng Qian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Changgeng Qian
Corporate Officer/Principal bij Central South University
Actieve functies van Changgeng Qian
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Central South University | Corporate Officer/Principal | 01-01-1992 | - |
Loopbaan van Changgeng Qian
Eerdere bekende functies van Changgeng Qian
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CURIS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2001 | 16-02-2012 |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-11-1999 | 01-05-2001 |
LeukoSite, Inc.
![]() LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-10-1996 | 01-11-1999 |
CytoMed, Inc.
![]() CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Corporate Officer/Principal | 01-12-1995 | 01-12-1995 |
Opleiding van Changgeng Qian
Central South University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
China | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CURIS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
LeukoSite, Inc.
![]() LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
CytoMed, Inc.
![]() CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Health Technology |
- Beurs
- Insiders
- Changgeng Qian
- Ervaring